Following Robert F. Kennedy Jr.’s appointment, the CDC indefinitely postponed a vaccine advisory committee meeting and discontinued its “Wild to Mild” flu vaccine campaign. The campaign’s removal, amidst a severe flu season, occurred after the Department of Health and Human Services instructed the CDC to emphasize “informed consent” in vaccine messaging. Experts warn that overemphasizing potential vaccine risks, however minimal, could discourage vaccination uptake. This shift in messaging raises concerns about public health efforts to promote vital preventative healthcare.
Read More
The Trump administration abruptly halted the CDC’s successful “Wild to Mild” flu vaccination campaign, which used animal imagery to illustrate the vaccine’s effectiveness in reducing illness severity. The decision, made by the Department of Health and Human Services under Robert F. Kennedy Jr.’s leadership, comes despite the campaign’s proven success in improving public understanding of flu vaccines and amidst a severe flu season with record-high hospitalizations. The campaign’s digital presence has been removed, and further communication efforts are now suspended. This action has prompted concern among public health experts given the campaign’s positive impact on vaccination rates, particularly among high-risk groups.
Read More
The USDA conditionally licensed Zoetis’ avian flu vaccine for chickens, aiming to combat the devastating outbreak impacting egg prices. This conditional license, granted due to the vaccine’s demonstrated safety and efficacy, offers a potential solution to the ongoing crisis. While the US historically prioritized eradication through culling, the vaccine’s approval signals a potential shift in strategy, given the virus’s increasing spread and severity. The high cost of eggs is expected to persist into 2025, driven by the outbreak and broader inflation.
Read More
John Q. Hosedrinker